Henshaw Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Henshaw Capital’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,898	Closed	-$284K	–	370
2021 Q1	$284K	Sell	11,898 -3,256	-21%	-$60.5K	0.02%	281
2020 Q4	$221K	Buy	15,154 +2,527	+20%	+$33.5K	0.02%	316
2020 Q3	$179K	Buy	+12,627	New	+$193K	0.01%	299

Henshaw Capital's GNMK Position: Q2 2021 in Review

Henshaw Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 11,898 shares — an estimated $284K sold.

Henshaw Capital first reported a position in GNMK in Q3 2020 and held it in 3 quarters. The position peaked at $284K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Henshaw Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Henshaw Capital sold 11,898 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $284K.
Henshaw Capital first reported a position in GenMark Diagnostics, Inc in Q3 2020 and held it in 3 quarters.
Henshaw Capital's GenMark Diagnostics, Inc position peaked at $284K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Henshaw Capital's 13F filing for Q2 2021, filed 28 May 2026.